(S (NP-SBJ Interleukin-4/NN) (VP inhibits/VBZ (NP (NP the/DT (NP-COOD (NP (NP lipopolysaccharide-induced/JJ expression/NN) (PP of/IN (NP (NP-COOD (NP c-jun/NN) and/CC (NP c-fos/NN)) messenger/NN RNA/NN))) and/CC (NP activator/NN protein-1/NN binding/NN activity/NN))) (PP in/IN (NP human/JJ monocytes/NNS)))) ./.)
(S (NP-SBJ We/PRP) (VP studied/VBD (NP (NP the/DT effect/NN) (PP of/IN (NP (NP interleukin-4/NN) (PRN -LRB-/-LRB- (NP IL-4/NN) -RRB-/-RRB-))) (PP on/IN (NP (NP the/DT (NP (NP lipopolysaccharide/NN) (PRN -LRB-/-LRB- (NP LPS/NN) -RRB-/-RRB-)) induction/NN) (PP of/IN (NP two/CD immediate/JJ early/JJ genes/NNS (NP-COOD (NP c-fos/NN) and/CC (NP c-jun/NN)))))))) ./.)
(S (NP-SBJ These/DT genes/NNS) (VP encode/VBP (NP (NP proteins/NNS) (SBAR (WHNP-80 that/WDT) (S (NP-SBJ *T*-80/-NONE-) (VP form/VBP (NP (NP (NP the/DT dimeric/JJ complex/NN activator/NN protein-1/NN) (PRN -LRB-/-LRB- (NP AP-1/NN) -RRB-/-RRB-)) ,/, (SBAR (WHNP-81 which/WDT) (S (NP-SBJ *T*-81/-NONE-) (VP is/VBZ (ADJP-PRD active/JJ) (PP as/IN (NP a/DT transcriptional/JJ factor/NN))))))))))) ./.)
(S (NP-SBJ (NP Maximal/JJ accumulation/NN) (PP of/IN (NP (NP-COOD either/CC (NP c-fos/NN) and/CC (NP c-jun/NN)) (NP (NP messenger/NN RNA/NN) (PRN -LRB-/-LRB- (NP mRNA/NN) -RRB-/-RRB-))))) (VP occurred/VBD (PP-TMP (NP 30/CD minutes/NNS) after/IN (NP LPS/NN addition/NN))) ./.)
(S (SBAR-TMP (WHADVP-82 When/WRB) (S (NP-SBJ-83 cells/NNS) (VP were/VBD (VP treated/VBN (NP *-83/-NONE-) (PP with/IN (NP IL-4/NN)) (PP-TMP for/IN (NP 5/CD hours/NNS)) (PP-TMP before/IN (NP LPS/NN activation/NN)) (ADVP *T*-82/-NONE-))))) ,/, (NP-SBJ-84 (NP-COOD both/CC (NP the/DT c-fos/NN (NP *RNR*-85/-NONE-)) and/CC (NP the/DT c-jun/NN (NP *RNR*-85/-NONE-))) (NP-85 mRNA/NN expression/NN)) (VP was/VBD (VP decreased/VBN (NP *-84/-NONE-))) ./.)
(S (NP-SBJ-86 (NP The/DT inhibition/NN) (PP of/IN (NP (NP-COOD (NP c-fos/NN) and/CC (NP c-jun/NN)) expression/NN)) (PP by/IN (NP IL-4/NN)) (PP in/IN (NP LPS-treated/JJ cells/NNS))) (VP was/VBD (VP shown/VBN (S (NP-SBJ *-86/-NONE-) (VP to/TO (VP be/VB (PP-PRD due/JJ to/TO (NP (NP a/DT lower/JJR transcription/NN rate/NN) (PP of/IN (NP the/DT (NP-COOD (NP c-fos/NN) and/CC (NP c-jun/NN)) genes/NNS))))))))) ./.)
(S (NP-SBJ IL-4/NN) (VP did/VBD not/RB (VP affect/VB (NP (NP the/DT stability/NN) (PP of/IN (NP the/DT (NP-COOD (NP c-fos/NN) and/CC (NP c-jun/NN)) transcripts/NNS))))) ./.)
(S (ADVP-TMP Finally/RB) ,/, (S (NP-SBJ */-NONE-) (VP using/VBG (NP electrophoretic/JJ mobility/NN shift/NN assays/NNS))) ,/, (NP-SBJ-101 evidence/NN (SBAR *ICH*-100/-NONE-)) (VP was/VBD (VP obtained/VBN (NP *-101/-NONE-) (SBAR-100 that/IN (S (NP-SBJ IL-4/NN) (VP inhibits/VBZ (NP (NP LPS-induced/JJ expression/NN) (PP of/IN (NP AP-1/NN protein/NN)))))))) ./.)
(S (NP-SBJ These/DT data/NNS) (VP indicate/VBP (SBAR that/IN (S (NP-SBJ IL-4/NN) (VP suppresses/VBZ (NP (NP the/DT induction/NN) (PP of/IN (NP transcription/NN factors/NNS)) (PP in/IN (NP human/JJ activated/VBN monocytes/NNS))))))) ./.)
